Sobha, Glenmark Pharma, 5 other stocks analysts recommend for long-term investment
These stocks belong to different spaces, from real estate to FMCG to automobiles.
Looking for long-term stock investment ideas on Dalal Street? Analysts at various brokerages have handpicked a bunch of stocks worth buying at the current juncture, including Maruti Suzuki, Godrej Consumer Products, Glenmark Pharma, and Birla Corporation. These stocks belong to different spaces, including real estate, FMCG, and automobiles.
(Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.)
Buy Maruti Suzuki shares, target price Rs 14,975, says KRChoksey
KRChoksey has recommended buying the Maruti Suzuki India stock for a target of Rs 14,975 with an upside of 16.4 per cent. The brokerage expected that operating margins would remain steady for the next 2 years due to factors like better pricing, cost reduction and FX benefits, offset by new capacity and an entry-level car revival. They also project the financials: EBITDA, PAT CAGR and revenue of 21.1 per cent, 26.4 per cent and 13.9 per cent in FY24-FY26E, respectively.
Buy Sobha shares, target price Rs 1,876, says Nuvama
Nuvama has recommended buying Sobha shares for a target of Rs 1,876. As of April 9, 2024 the stock was trading around Rs 1,630. Hence, the stock can rise to 14.03 per cent.
Buy Birla Corporation shares, target price Rs 1,665, says Axis Securities
Axis Securities has a 'buy' call on the Birla Corporation stock with a target of Rs 1,665. The brokerage expected that the company would grow its sales, EBITDA, APAT at a CAGR of 10 per cent, 15 per cent and 43 per cent, respectively, from FY24 to FY26E.
Buy Godrej Consumer shares, target price Rs 1,455, says Nuvama
Nuvama has a 'buy' call on the Godrej Consumer Products Ltd stock with a target of Rs 1,455.
Buy Glenmark Pharma shares, target price Rs 1,266, says KRChoksey
KRChoksey has a 'buy' call on the Glenmark Pharmaceuticals stock with a target of Rs 1,266.
Buy Prestige Estates, Macrotech Developers
Nuvama has a 'buy' call on two real estate stocks: Prestige Estates and Macrotech Developers. The brokerage has kept targets for the stock of Rs 1,627 and Rs 1,431, respectively.